IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 149 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,056,000 | +1.1% | 781,339 | -1.8% | 0.27% | +8.0% |
| Q4 2017 | $11,927,000 | +5.0% | 795,659 | +10.5% | 0.25% | +1.2% |
| Q3 2017 | $11,355,000 | -8.8% | 720,069 | +9.2% | 0.25% | -6.8% |
| Q2 2017 | $12,452,000 | +22.5% | 659,509 | +10.7% | 0.26% | +20.5% |
| Q1 2017 | $10,165,000 | +7.2% | 595,835 | -4.0% | 0.22% | +2.3% |
| Q4 2016 | $9,485,000 | +53.0% | 620,345 | +58.9% | 0.21% | +81.4% |
| Q3 2016 | $6,200,000 | +21.4% | 390,435 | 0.0% | 0.12% | +15.7% |
| Q2 2016 | $5,105,000 | +26.4% | 390,435 | +5.8% | 0.10% | +27.5% |
| Q1 2016 | $4,038,000 | – | 369,085 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |